EMA reports a steady rise in clinical trial applications registered in the CTIS portal (Cell and Gene Therapy Catapult – Regulatory Round-up – August 2022)
Nearly 195 clinical trial applications (CTAs) have been submitted to the European Medicine Agency’s (EMA) Clinical Trial Information System (CTIS) portal from 1st Jan 2022 through to 31st July 2022, marking a substantial increase from a month earlier, according to the 4th Edition of the EMA’s “Key performance indicators (KPIs) to monitor the European clinical trials environment” report.
See all of Catapult’s Regulatory Round-up for August 2022 here.
Published on the 1st of september 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (26 octobre 2022). EMA reports a steady rise in clinical trial applications registered in the CTIS portal (Cell and Gene Therapy Catapult – Regulatory Round-up – August 2022). ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/o63r





